Welcome to our dedicated page for DGNU news (Ticker: DGNU), a resource for investors and traders seeking the latest updates and insights on DGNU stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DGNU's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DGNU's position in the market.
Dragoneer Growth Opportunities Corp. III (Nasdaq: DGNU) announced its inability to complete an initial business combination within the designated timeframe, leading to plans for dissolution and liquidation. The company will redeem all outstanding Class A ordinary shares at an estimated price of $10.00 per share as of March 24, 2023. This includes liquidating the trust account, where funds will be held in a non-interest bearing account until disbursed to shareholders. Nasdaq will also file a Form 25 to delist the company's securities and a Form 15 to terminate the registration under the Exchange Act.
Dragoneer Growth Opportunities Corp. III has priced its initial public offering (IPO) of 40,000,000 Class A ordinary shares at $10.00 each. Trading is set to commence on the Nasdaq under the ticker symbol DGNU on March 25, 2021, pending customary closing conditions. The company has also entered into a forward purchase agreement for 5,000,000 shares with affiliates. Citigroup, Goldman Sachs, and J.P. Morgan are the book-running managers for the offering, which includes a 45-day option for underwriters to purchase an additional 6,000,000 shares.
FAQ
What is the market cap of DGNU (DGNU)?
